February 2, 2022
- Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control
- How Bigfoot Biomedical plans to take diabetes management forward
- Provention Bio Resubmitting Biologics License Application for Delay of Clinical Type 1 Diabetes in At-Risk Individuals Following Type B Meeting with the FDA
- Federal Court Rules Children with Diabetes in NYC Denied Equal Access to Field Trips and Bus Transportation
- Glooko Acquires Germany-Based xbird, a Medical AI Company